| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 2043-2050, Copyright © 1996 by Endocrine Society
ARTICLES |
BA Boston and RD Cone
Department of Pediatrics, Oregon Health Sciences University, Portland 97201, USA.
It has been known for many years that adipocytes express high affinity ACTH and alpha-melanocyte stimulating hormone (MSH) binding sites, and that ACTH, alpha-MSH, and beta-lipotropin are potent lipolytic hormones. We show here that the adipocyte response to the melanocortin peptides results from the expression of both the MC2 (ACTH) receptor as well as the newly discovered MC5 receptor. Using RT-PCR and Northern blot hybridization, high levels of MC2 receptor messenger RNA (mRNA) were found in all adipose tissues examined in the mouse, whereas MC5 receptor mRNA was found in a subset of these. Both receptors mRNAs were also found in the 3T3-L1 cell line but only after the cells had been induced to differentiate into adipocytes. This cell line was then used to characterize the pharmacological properties of the MC2 and MC5 receptor sites in situ. The MC2 receptor exhibits properties similar to the ACTH receptor characterized in adrenocortical cells, coupling to activation of adenylyl cyclase with an EC50 of approximately 1 nM. An MSH binding site characterized in these cells is presumably the MC5 receptor, based on the observation that this is the only other melanocortin receptor mRNA detected in these cells. The MC5 receptor in the 3T3-L1 adipocyte activated adenylyl cyclase in response to alpha- MSH stimulation. Interestingly, Nle4, D-Phe7-alpha-MSH (NDP-MSH), a commonly used synthetic alpha-MSH agonist, was a potent antagonist of the MC5 receptor expressed in the 3T3-L1 cell line. Although the agouti signaling peptide is a potent antagonist of NDP-MSH binding to the MC1 and MC4 melanocortin receptors, agouti was unable to block NDP-MSH binding in the 3T3-L1 adipocyte.
This article has been cited by other articles:
![]() |
K A. H Iwen, O. Senyaman, A. Schwartz, M. Drenckhan, B. Meier, D. Hadaschik, and J. Klein Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes J. Endocrinol., March 1, 2008; 196(3): 465 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C Harmer, D. J Pepper, K. Cooke, H. P J Bennett, and A. B Bicknell Evidence of a possible role for Lys-{gamma}3-MSH in the regulation of adipocyte function J. Endocrinol., January 1, 2008; 196(1): 149 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Doufexis, H. L. Storr, P. J. King, and A. J. L. Clark Interaction of the melanocortin 2 receptor with nucleoporin 50: evidence for a novel pathway between a G-protein-coupled receptor and the nucleus FASEB J, December 1, 2007; 21(14): 4095 - 4100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chida, S. Nakagawa, S. Nagai, H. Sagara, H. Katsumata, T. Imaki, H. Suzuki, F. Mitani, T. Ogishima, C. Shimizu, et al. Melanocortin 2 receptor is required for adrenal gland development, steroidogenesis, and neonatal gluconeogenesis PNAS, November 13, 2007; 104(46): 18205 - 18210. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Strader, H. Shi, R. Ogawa, R. J. Seeley, and O. Reizes The Effects of the Melanocortin Agonist (MT-II) on Subcutaneous and Visceral Adipose Tissue in Rodents J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1153 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Muller, N. Schweitzer, O. Johren, P. Dominiak, and W. Raasch Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E802 - E810. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Zhang, K. M. Gauthier, J. R. Falck, A. Siddam, and W. B. Campbell Steroid-Producing Cells Regulate Arterial Tone of Adrenal Cortical Arteries Endocrinology, August 1, 2007; 148(8): 3569 - 3576. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hiroyama, T. Aoyagi, Y. Fujiwara, J. Birumachi, Y. Shigematsu, K. Kiwaki, R. Tasaki, F. Endo, and A. Tanoue Hypermetabolism of Fat in V1a Vasopressin Receptor Knockout Mice Mol. Endocrinol., January 1, 2007; 21(1): 247 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Noon, A. J. L. Clark, P. J. O'Shaughnessy, and P. J. King A CCAAT/Enhancer-Binding Protein Site at -87 Is Required for the Activation of a Novel Murine Melanocortin 2-Receptor Promoter at Late Stages during Adipogenesis Endocrinology, December 1, 2006; 147(12): 6019 - 6026. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Song, R. M. Jackson, R. B. S. Harris, D. Richard, and T. J. Bartness Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1467 - R1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bohm, M. Eickelmann, Z. Li, S. W. Schneider, V. Oji, S. Diederichs, G. S. Barsh, A. Vogt, K. Stieler, U. Blume-Peytavi, et al. Detection of Functionally Active Melanocortin Receptors and Evidence for an Immunoregulatory Activity of {alpha}-Melanocyte-Stimulating Hormone in Human Dermal Papilla Cells Endocrinology, November 1, 2005; 146(11): 4635 - 4646. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zwermann, D. M Schulte, M. Reincke, and F. Beuschlein ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo Eur. J. Endocrinol., September 1, 2005; 153(3): 435 - 444. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fricke, A. Schulz, H. John, W.-G. Forssmann, and E. Maronde Isolation and Characterization of a Novel Proopiomelanocortin-Derived Peptide from Hemofiltrate of Chronic Renal Failure Patients Endocrinology, April 1, 2005; 146(4): 2060 - 2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Hoggard, D V Rayner, S L Johnston, and J R Speakman Peripherally administered [Nle4,D-Phe7]-{alpha}-melanocyte stimulating hormone increases resting metabolic rate, while peripheral agouti-related protein has no effect, in wild type C57BL/6 and ob/ob mice J. Mol. Endocrinol., December 1, 2004; 33(3): 693 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Noon, A. J. L. Clark, and P. J. King A Peroxisome Proliferator-response Element in the Murine mc2-r Promoter Regulates Its Transcriptional Activation during Differentiation of 3T3-L1 Adipocytes J. Biol. Chem., May 28, 2004; 279(22): 22803 - 22808. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Morris, B. Kola, N. Borboli, G. A. Kaltsas, M. Gueorguiev, A. M. McNicol, R. Ferrier, T. H. Jones, S. Baldeweg, M. Powell, et al. Identification of Adrenocorticotropin Receptor Messenger Ribonucleic Acid in the Human Pituitary and Its Loss of Expression in Pituitary Adenomas J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 6080 - 6087. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Smith, B. Gawronska-Kozak, L. Janderova, T. Nguyen, A. Murrell, J. M. Stephens, and R. L. Mynatt Agouti Expression in Human Adipose Tissue: Functional Consequences and Increased Expression in Type 2 Diabetes Diabetes, December 1, 2003; 52(12): 2914 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. O'Shaughnessy, L. M. Fleming, G. Jackson, U. Hochgeschwender, P. Reed, and P. J. Baker Adrenocorticotropic Hormone Directly Stimulates Testosterone Production by the Fetal and Neonatal Mouse Testis Endocrinology, August 1, 2003; 144(8): 3279 - 3284. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. MYNATT and J. M. STEPHENS Regulation of PPAR{gamma} and Obesity by Agouti/Melanocortin Signaling in Adipocytes Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cornish, K. E. Callon, K. G. Mountjoy, U. Bava, J.-M. Lin, D. E. Myers, D. Naot, and I. R. Reid alpha -Melanocyte-stimulating hormone is a novel regulator of bone Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1181 - E1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Pierroz, M. Ziotopoulou, L. Ungsunan, S. Moschos, J. S. Flier, and C. S. Mantzoros Effects of Acute and Chronic Administration of the Melanocortin Agonist MTII in Mice With Diet-Induced Obesity Diabetes, May 1, 2002; 51(5): 1337 - 1345. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Lincoln, S. M. Rhind, S. Pompolo, and I. J. Clarke Hypothalamic control of photoperiod-induced cycles in food intake, body weight, and metabolic hormones in rams Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R76 - R90. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Mynatt and J. M. Stephens Agouti regulates adipocyte transcription factors Am J Physiol Cell Physiol, April 1, 2001; 280(4): C954 - C961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lacroix, N. N'Diaye, J. Tremblay, and P. Hamet Ectopic and Abnormal Hormone Receptors in Adrenal Cushing's Syndrome Endocr. Rev., February 1, 2001; 22(1): 75 - 110. [Abstract] [Full Text] |
||||
![]() |
H. Hatakeyama, S. Inaba, N. Taniguchi, and I. Miyamori Functional Adrenocorticotropic Hormone Receptor in Cultured Human Vascular Endothelial Cells : Possible Role in Control of Blood Pressure Hypertension, November 1, 2000; 36(5): 862 - 865. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Slominski and J. Wortsman Neuroendocrinology of the Skin Endocr. Rev., October 1, 2000; 21(5): 457 - 487. [Abstract] [Full Text] |
||||
![]() |
A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress Physiol Rev, July 1, 2000; 80(3): 979 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Haycock, S. J. Rowe, S. Cartledge, A. Wyatt, G. Ghanem, R. Morandini, I. G. Rennie, and S. MacNeil alpha -Melanocyte-stimulating Hormone Reduces Impact of Proinflammatory Cytokine and Peroxide-generated Oxidative Stress on Keratinocyte and Melanoma Cell Lines J. Biol. Chem., May 19, 2000; 275(21): 15629 - 15636. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. BOSTON The Role of Melanocortins in Adipocyte Function Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 75 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. LERNER Synthetic Melanocortin Receptor Agonists and Antagonists Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. TEOFOLI, A. FREZZOLINI, P. PUDDU, O. DE PITA, A. MAUVIEL, and T. LOTTI The Role of Proopiomelanocortin-Derived Peptides in Skin Fibroblast and Mast Cell Functions Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 268 - 276. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. G. Mountjoy, D. H. Willard, and W. O. Wilkison Agouti Antagonism of Melanocortin-4 Receptor: Greater Effect with Desacetyl-{alpha}-Melanocyte-Stimulating Hormone (MSH) than with {alpha}-MSH Endocrinology, May 1, 1999; 140(5): 2167 - 2172. [Abstract] [Full Text] |
||||
![]() |
R. Qiu, C. Frigeri, and B. P. Schimmer A Role for Guanyl Nucleotide-Binding Regulatory Protein {beta}- and {gamma}-Subunits in the Expression of the Adrenocorticotropin Receptor Mol. Endocrinol., December 1, 1998; 12(12): 1879 - 1887. [Abstract] [Full Text] |
||||
![]() |
B. Xue, N. Moustaid-moussa, W. O. Wilkison, and M. B. Zemel The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism FASEB J, October 1, 1998; 12(13): 1391 - 1396. [Abstract] [Full Text] |
||||
![]() |
T. A. LUGER, T. SCHOLZEN, T. BRZOSKA, E. BECHER, A. SLOMINSKI, and R. PAUS Cutaneous Immunomodulation and Coordination of Skin Stress Responses by {alpha}-Melanocyte-Stimulating Hormone Ann. N.Y. Acad. Sci., May 1, 1998; 840(1): 381 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Miltenberger, R. L. Mynatt, J. E. Wilkinson, and R. P. Woychik The Role of the agouti Gene in the Yellow Obese Syndrome J. Nutr., September 1, 1997; 127(9): 1902 - 1902. [Abstract] [Full Text] |
||||
![]() |
F. M. Cammas, G. D. Pullinger, S. Barker, and A. J. L. Clark The Mouse Adrenocorticotropin Receptor Gene: Cloning and Characterization of Its Promoter and Evidence for a Role for the Orphan Nuclear Receptor Steroidogenic Factor 1 Mol. Endocrinol., June 1, 1997; 11(7): 867 - 876. [Abstract] [Full Text] |
||||
![]() |
F.-S. Shen and Y. P. Loh Intracellular misrouting and abnormal secretion of adrenocorticotropin and growth hormone in Cpefat mice associated with a carboxypeptidase E mutation PNAS, May 13, 1997; 94(10): 5314 - 5319. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Mynatt, R. J. Miltenberger, M. L. Klebig, M. B. Zemel, J. E. Wilkinson, W. O. Wilkison, and R. P. Woychik Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity PNAS, February 4, 1997; 94(3): 919 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Baig, F. M. Swords, L. A. Noon, P. J. King, L. Hunyady, and A. J. L. Clark Desensitization of the Y1 Cell Adrenocorticotropin Receptor. EVIDENCE FOR A RESTRICTED HETEROLOGOUS MECHANISM IMPLYING A ROLE FOR RECEPTOR-EFFECTOR COMPLEXES J. Biol. Chem., November 21, 2001; 276(48): 44792 - 44797. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. XUE, W. O. WILKISON, R. L. MYNATT, N. MOUSTAID, M. GOLDMAN, and M. B. ZEMEL The agouti gene product stimulates pancreatic {beta}-cell Ca2+ signaling and insulin release Physiol Genomics, July 15, 1999; 1(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |